Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04456140 · ClinicalTrials.gov registry record · Phase 1
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
A Phase 1 study of Malignant Solid Neoplasm and Breast Carcinoma, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 230
- Enrollment target
- 2
- Study locations
NCT04456140: Completed Phase 1 study of Malignant Solid Neoplasm and Breast Carcinoma, sponsored by Mayo Clinic.
NCT04456140 is a Phase 1 study of Malignant Solid Neoplasm and Breast Carcinoma that has completed, run by Mayo Clinic. The registered enrollment target is 230 participants, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04456140, a Phase 1 study of Malignant Solid Neoplasm and Breast Carcinoma, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 230 participants
- Enrollment target
- 2
- Study locations
Study Summary
This phase I trial collects blood samples to investigate the prevalence of changes in genes (genetic mutations) in solid tumor patient populations seeking care at Mayo Clinic Embedded Cancer Center at St. Vincent's Riverside. This may help doctors better understand and/or treat others who have genetic mutations.
Primary Outcome
Will be assessed by each cancer site, age (\< 60 years old versus \[vs.\] \>= 60 years old), and stage (early vs. advanced) via descriptive statistics.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Survey Administration
- OTHER Genetic Testing
- OTHER Genetic Counseling
Study Locations (2)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2020-06-29 |
| Est. Completion | 2021-09-21 |
| Phase | Phase 1 |
What the finished NCT04456140 record still lists
NCT04456140 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (80% lower).
The record links to 10 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT04456140 reports a single indexed study location in Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT04456140 about?
NCT04456140 is a clinical study titled "Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study". This phase I trial collects blood samples to investigate the prevalence of changes in genes (genetic mutations) in solid tumor patient populations seeking care at Mayo Clinic Embedded Cancer Center at St. Vincent's Riverside. This may help doctors better understand and/or treat others who have genet...
What is the current status of trial NCT04456140?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 230 participants. The study started on 2020-06-29. Estimated completion is 2021-09-21.
What conditions does trial NCT04456140 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Breast Carcinoma, Malignant Female Reproductive System Neoplasm, Malignant Brain Neoplasm, Malignant Head and Neck Neoplasm.
What interventions are being tested in trial NCT04456140?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Genetic Testing (OTHER), Genetic Counseling (OTHER).
Who is sponsoring clinical trial NCT04456140?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04456140 being conducted?
This trial has 2 study locations across Arizona, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04456140's enrollment target sits among peer trials
230 57th of 176 higher than 120 of 176 other Malignant Solid Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
RECRUITING · Phase 1
-
Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients
RECRUITING · Phase 1
-
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
RECRUITING · Phase 1
-
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
RECRUITING · Phase 1
-
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI